Results 171 to 180 of about 4,425,847 (185)
Some of the next articles are maybe not open access.

[The cytotoxicity and mechanism of CIK cells to breast cancer cells ZK-75-1].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2009
To study the cytotoxicity and mechanism of cytokine-induced killer (CIK) cells to breast cancer cell line ZK-75-1.The morphological changes of ZK-75-1 cells were observed by HE staining. The apoptosis of ZK-75-1 cell line was examined by TUNEL staining.
Xiang-dan, Li   +4 more
openaire   +1 more source

Biological activity of DC-CIK cells and its effect against leukemia cells in vitro.

Zhongguo shi yan xue ye xue za zhi, 2011
This study was aimed to investigate the effect of dendritic cells (DC) on the proliferation capability, immunophenotype changes, level of secreted cytokines and activity against leukemia of cytokine-induced killer (CIK) cells in vitro. DCs and CIK cells were induced from peripheral blood mononuclear cells of healthy volunteers.
Xu-Cang, Wei   +4 more
openaire   +1 more source

[Biological characteristics of PHA-induced CIK cells and its killing activity to K562 cells].

Zhongguo shi yan xue ye xue za zhi, 2014
The purpose of study was to investigate the in vitro proliferation ability of PHA-induced CIK cells and traditionally prepared CIK cells, the effector cell level and its influence on killing activity to K562 cells, and to analyze the difference between them. The peripheral blood mononuclear cells(PBMNC) of healthy persons were isolated and divided into
Mou-Zhen, Huang   +6 more
openaire   +1 more source

Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)

Journal of Cancer Research and Clinical Oncology, 2014
Leonard Christopher Schmeel   +2 more
exaly  

Thymoglobuline in efficient expansion of cytokine induced killer (CIK) cells and possibility of CIK cell clinical application in posttransplant setting

Bone Marrow Transplantation, 2014
Monika Mielcarek   +5 more
openaire   +1 more source

Combinatorial approach with Cytokine-Induced Killer (CIK) cells and immunotools to fight HER2-positive breast cancer. Culture optimization of CIK cell expansion and function.

Targeting HER2 molecules for HER2+ breast cancer has become the standard care for both early and advanced-stage disease, on the other hand the treatment of metastatic HER+ tumors that develop resistance and lead to a disease progression, remained a barrier.
openaire   +1 more source

Home - About - Disclaimer - Privacy